Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Nov 30, 2017)
  • 8-K (Nov 22, 2017)
  • 8-K (Nov 14, 2017)
  • 8-K (Nov 3, 2017)
  • 8-K (Oct 31, 2017)
  • 8-K (Oct 24, 2017)

 
Other

Express Scripts 8-K 2009

Documents found in this filing:

  1. 8-K
  2. Ex-99.1
  3. Graphic
  4. Graphic
  5. Graphic
e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): December 1, 2009 (December 1, 2009)
Express Scripts, Inc.
(Exact Name of Registrant as Specified in its Charter)
         
Delaware
(State or Other Jurisdiction of Incorporation)
  0-20199
(Commission File Number)
  43-1420563
(I.R.S. Employer Identification No.)
One Express Way,
St. Louis, MO 63121
(Address, including zip code, of principal executive offices)
Registrant’s telephone number, including area code: 314-996-0900
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a- 12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 2.01 Completion of Acquisition or Disposition of Assets.
     On December 1, 2009, the Company consummated its previously announced purchase (the “Acquisition”) of all of the shares and equity interests of three WellPoint subsidiaries, NextRx, Inc., NextRx Services, Inc., and NextRx, LLC, that provide pharmacy benefits management services (the “PBM Business”) for a purchase price of $4,675,000,000, subject to certain working capital, indebtedness and other adjustments set forth in that certain Stock and Interest Purchase Agreement, dated April 9, 2009, by and between the Company and WellPoint (the “Purchase Agreement”). On November 24, 2009, the Company provided WellPoint with its irrevocable election to pay the aggregate consideration due in connection with the Acquisition in the form of cash. The Company financed the acquisition with the Company’s existing cash resources and a combination of new debt and equity offerings completed in June 2009.
     On December 1, 2009, the Company issued a press release announcing the completion of the Acquisition. A copy of that press release is attached as Exhibit 99.1.
     A copy of the Purchase Agreement is attached as Exhibit 2.1 to the Current Report on Form 8-K dated April 14, 2009. The foregoing description of the Purchase Agreement is not complete and is qualified in its entirety by reference to the full text of the Purchase Agreement.
Item 9.01 Financial Statements and Exhibits.
The information required by Item 9.01(a) and (b), if any, will be filed by amendment not later than 75 calendar days after the date of this initial report on Form 8-K.
(d) Exhibits
     The following exhibit is attached hereto and filed herewith.
     
Exhibit    
No.   Description
99.1
  Press release dated December 1, 2009.

 


 

Signatures
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Dated: December 1, 2009  Express Scripts, Inc.
 
 
  By:   /s/ Jeffrey Hall    
    Jeffrey Hall   
    Executive Vice President and Chief Financial Officer   

 


 

         
Exhibit Index
     
Exhibit    
No.   Description
 
   
99.1
  Press release dated October 1, 2009.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki